| RS145387989 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS1453883641 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1453886049 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS145388804 |
IMPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS145389125 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, FAH-related disorder |
| RS145389285 |
KATNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Lissencephaly 6 with microcephaly |
| RS1453893690 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1453894904 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1453899480 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1453901558 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1453901762 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect 4, Atrioventricular septal defect 4 |
| RS145390254 |
NDST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS145390629 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS1453915867 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1453919511 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1453920894 |
PGM1
|
Health Risk |
Pathogenic/Likely pathogenic |
PGM1-congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS145392420 |
TNFAIP3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145392789 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1453933519 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1453934366 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1453934715 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS145393807 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 6 |
| RS145393882 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS145394391 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group C |
| RS145394914 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1453953571 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS145396188 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS1453967813 |
PNPLA6;MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Hereditary spastic paraplegia 39 |
| RS1453968760 |
TANGO2
|
Health Risk |
Pathogenic |
— |
| RS145397619 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1453977337 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS1453982069 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1453983744 |
PKP2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Arrhythmogenic right ventricular dysplasia 9 |
| RS145398548 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Inborn genetic diseases |
| RS1453987164 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS145398861 |
LIPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia due to hepatic triglyceride lipase deficiency, Hyperlipidemia due to hepatic triglyceride lipase deficiency |
| RS1453992981 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS145400360 |
DRC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS145400611 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1454006905 |
POMK
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS145400780 |
IQCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, IQCB1-related disorder |
| RS1454008881 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS145401010 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS145401144 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS145401372 |
MPZL2
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive 111 |
| RS145401873 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS145402041 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Dilated cardiomyopathy 1C |
| RS145402131 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1454033665 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS145403829 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS145404046 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Ehlers-Danlos syndrome |
| RS145404396 |
PHYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonsyndromic cleft lip palate, Phytanic acid storage disease |
| RS145404739 |
NUP85
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1454054574 |
CYB5R3
|
Health Risk |
Likely pathogenic |
Deficiency of cytochrome-b5 reductase, Deficiency of cytochrome-b5 reductase |
| RS1454055874 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1454068577 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS145407020 |
NDUFS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS145407228 |
TRPC5
|
Health Risk |
Conflicting classifications of pathogenicity |
TRPC5-related disorder, TRPC5-related disorder |
| RS145408029 |
DYM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DYM-related disorder |
| RS1454083299 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1454088856 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS145410000 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS145411537 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS145411666 |
SLC25A12
|
Health Risk |
Pathogenic |
— |
| RS145412418 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Autoinflammatory syndrome |
| RS1454126964 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tangier disease, Hypoalphalipoproteinemia |
| RS145412880 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, DYSF-related disorder |
| RS1454140894 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1454141074 |
IHH
|
Health Risk |
Likely pathogenic |
Acrocapitofemoral dysplasia, Acrocapitofemoral dysplasia |
| RS145414319 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, See cases |
| RS145415033 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS145415848 |
CIB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1J, Usher syndrome type 1 |
| RS1454163044 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS1454175058 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1454183075 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, Sitosterolemia |
| RS145419117 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS145419141 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS145420388 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS145420448 |
ADAMTS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, Weill-Marchesani syndrome |
| RS1454219963 |
MEGF10
|
Health Risk |
Likely pathogenic |
— |
| RS1454220856 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Hereditary spastic paraplegia 74 |
| RS145422395 |
HADHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1454231642 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS1454234098 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS145424390 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS145424773 |
DLX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism, Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism |
| RS145425340 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS145425478 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Left ventricular noncompaction 1 |
| RS145425662 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145425679 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145427063 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS145427253 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Ventricular fibrillation, paroxysmal familial |
| RS145427664 |
HMOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
HMOX1-related disorder, HMOX1-related disorder |
| RS145427732 |
DHTKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2Q, 2-aminoadipic 2-oxoadipic aciduria |
| RS145427892 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolcott-Rallison dysplasia, Connective tissue disorder |
| RS145428184 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS145428904 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1454289985 |
CLTC
|
Health Risk |
Pathogenic |
— |
| RS1454292836 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1454293516 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |